B-intervention	0	4	Yoga
O	5	8	and
O	9	13	self
O	13	14	-
O	14	22	reported
O	23	32	cognitive
O	33	41	problems
O	42	44	in
O	45	51	breast
O	52	58	cancer
O	59	68	survivors
O	68	69	:
O	70	71	a
O	72	82	randomized
O	83	93	controlled
O	94	99	trial
O	99	100	.

O	101	107	Cancer
O	108	117	survivors
O	118	123	often
O	124	130	report
O	131	140	cognitive
O	141	149	problems
O	149	150	.

O	151	162	Furthermore
O	162	163	,
O	164	173	decreases
O	174	176	in
O	177	185	physical
O	186	194	activity
O	195	204	typically
O	205	210	occur
O	211	215	over
O	216	219	the
O	220	226	course
O	227	229	of
O	230	236	cancer
O	237	246	treatment
O	246	247	.

O	248	256	Although
O	257	265	physical
O	266	274	activity
O	275	283	benefits
O	284	293	cognitive
O	294	302	function
O	303	305	in
O	306	315	noncancer
O	316	327	populations
O	327	328	,
O	329	337	evidence
O	338	345	linking
O	346	354	physical
O	355	363	activity
O	364	366	to
O	367	376	cognitive
O	377	385	function
O	386	388	in
O	389	395	cancer
O	396	405	survivors
O	406	408	is
O	409	416	limited
O	416	417	.

O	418	420	In
O	421	424	our
O	425	431	recent
O	432	442	randomized
O	443	453	controlled
O	454	459	trial
O	459	460	,
O	461	467	breast
O	468	474	cancer
O	475	484	survivors
O	485	488	who
O	489	497	received
O	498	499	a
O	500	504	yoga
O	505	517	intervention
O	518	521	had
O	522	527	lower
O	528	535	fatigue
O	536	539	and
O	540	552	inflammation
O	553	562	following
O	563	566	the
O	567	572	trial
O	573	581	compared
O	582	586	with
O	587	588	a
O	589	593	wait
O	594	598	list
O	599	606	control
O	607	612	group
O	612	613	.

O	614	618	This
O	619	628	secondary
O	629	637	analysis
O	638	640	of
O	641	644	the
O	645	651	parent
O	652	657	trial
O	658	667	addressed
O	668	672	yoga
O	672	673	'
O	673	674	s
O	675	681	impact
O	682	684	on
O	685	694	cognitive
O	695	705	complaints
O	705	706	.

B-eligibility	707	720	Posttreatment
I-eligibility	721	726	stage
I-eligibility	727	728	0
I-eligibility	728	729	-
I-eligibility	729	733	IIIA
I-eligibility	734	740	breast
I-eligibility	741	747	cancer
I-eligibility	748	757	survivors
O	758	759	(
O	759	760	n
O	761	762	=
B-total-participants	763	766	200
O	766	767	)
O	768	772	were
O	773	783	randomized
O	784	786	to
O	787	788	a
O	789	791	12
O	791	792	-
O	792	796	week
O	796	797	,
O	798	803	twice
O	803	804	-
O	804	810	weekly
O	811	816	Hatha
O	817	821	yoga
O	822	834	intervention
O	835	837	or
O	838	839	a
B-control	840	844	wait
I-control	845	849	list
I-control	850	857	control
I-control	858	863	group
O	863	864	.

O	865	877	Participants
O	878	886	reported
O	887	896	cognitive
O	897	907	complaints
O	908	913	using
O	914	917	the
O	918	924	Breast
O	925	931	Cancer
O	932	942	Prevention
O	943	948	Trial
O	949	958	Cognitive
O	959	967	Problems
O	968	973	Scale
O	974	976	at
O	977	985	baseline
O	985	986	,
O	987	998	immediately
O	999	1015	postintervention
O	1015	1016	,
O	1017	1020	and
O	1021	1022	3
O	1022	1023	-
O	1023	1028	month
O	1029	1035	follow
O	1035	1036	-
O	1036	1038	up
O	1038	1039	.

B-outcome	1040	1049	Cognitive
I-outcome	1050	1060	complaints
O	1061	1064	did
O	1065	1068	not
O	1069	1075	differ
O	1076	1089	significantly
O	1090	1097	between
O	1098	1104	groups
O	1105	1116	immediately
O	1117	1133	postintervention
O	1134	1135	(
O	1135	1136	p
O	1137	1138	=
O	1139	1140	0
O	1140	1141	.
O	1141	1144	250
O	1144	1145	)
O	1145	1146	.

O	1147	1154	However
O	1154	1155	,
O	1156	1158	at
O	1159	1160	3
O	1160	1161	-
O	1161	1166	month
O	1167	1173	follow
O	1173	1174	-
O	1174	1176	up
O	1176	1177	,
O	1178	1182	yoga
O	1183	1195	participants
O	1195	1196	'
O	1197	1203	Breast
O	1204	1210	Cancer
O	1211	1221	Prevention
O	1222	1227	Trial
B-outcome	1228	1237	Cognitive
I-outcome	1238	1246	Problems
I-outcome	1247	1252	Scale
I-outcome	1253	1259	scores
O	1260	1264	were
O	1265	1267	an
O	1268	1275	average
O	1276	1278	of
O	1279	1281	23
O	1281	1282	%
O	1283	1288	lower
O	1289	1293	than
O	1294	1298	wait
O	1299	1303	list
O	1304	1316	participants
O	1316	1317	'
O	1318	1324	scores
O	1325	1326	(
O	1326	1327	p
O	1328	1329	=
O	1330	1331	0
O	1331	1332	.
O	1332	1335	003
O	1335	1336	)
O	1336	1337	.

O	1338	1343	These
O	1344	1349	group
O	1350	1361	differences
O	1362	1364	in
B-outcome	1365	1374	cognitive
I-outcome	1375	1385	complaints
O	1386	1394	remained
O	1395	1400	after
O	1401	1412	controlling
O	1413	1416	for
O	1417	1430	psychological
O	1431	1439	distress
O	1439	1440	,
O	1441	1448	fatigue
O	1448	1449	,
O	1450	1453	and
O	1454	1459	sleep
O	1460	1467	quality
O	1467	1468	.

O	1469	1479	Consistent
O	1480	1484	with
O	1485	1488	the
O	1489	1496	primary
O	1497	1504	results
O	1504	1505	,
O	1506	1511	those
O	1512	1515	who
O	1516	1525	practiced
O	1526	1530	yoga
O	1531	1535	more
O	1536	1546	frequently
O	1547	1555	reported
O	1556	1569	significantly
O	1570	1575	fewer
B-outcome	1576	1585	cognitive
I-outcome	1586	1594	problems
I-outcome	1595	1597	at
I-outcome	1598	1599	3
I-outcome	1599	1600	-
I-outcome	1600	1605	month
I-outcome	1606	1612	follow
I-outcome	1612	1613	-
I-outcome	1613	1615	up
O	1616	1620	than
O	1621	1626	those
O	1627	1630	who
O	1631	1640	practiced
O	1641	1645	less
O	1646	1656	frequently
O	1657	1658	(
O	1658	1659	p
O	1660	1661	<
O	1662	1663	0
O	1663	1664	.
O	1664	1667	001
O	1667	1668	)
O	1668	1669	.

O	1670	1675	These
O	1676	1684	findings
O	1685	1692	suggest
O	1693	1697	that
O	1698	1702	yoga
O	1703	1706	can
O	1707	1718	effectively
O	1719	1725	reduce
O	1726	1732	breast
O	1733	1739	cancer
O	1740	1749	survivors
O	1749	1750	'
O	1751	1760	cognitive
O	1761	1771	complaints
O	1772	1775	and
O	1776	1782	prompt
O	1783	1790	further
O	1791	1799	research
O	1800	1802	on
O	1803	1807	mind
O	1807	1808	-
O	1808	1812	body
O	1813	1816	and
O	1817	1825	physical
O	1826	1834	activity
O	1835	1848	interventions
O	1849	1852	for
O	1853	1862	improving
O	1863	1869	cancer
O	1869	1870	-
O	1870	1877	related
O	1878	1887	cognitive
O	1888	1896	problems
O	1896	1897	.
